Skip to main content

Notice

We are in the process of rolling out a soft launch of the RDA website, which includes a new member platform. Existing RDA members PLEASE REACTIVATE YOUR ACCOUNT using this link: https://rda-login.wicketcloud.com/users/confirmation. Visitors may encounter functionality issues with group pages, navigation, missing content, broken links, etc. As you explore the new site, please provide your feedback using the UserSnap tool on the bottom right corner of each page. Thank you for your understanding and support as we work through all issues as quickly as possible. Stay updated about upcoming features and functionalities: https://www.rd-alliance.org/rda-web-platform-upcoming-features-and-functionalities/

#129802

Dawei Lin
Member

Hi Martin and Diana,
Thank you for letting us know that you can not attend the call.
These are a few deadlines:
1. Contributors list and References (from *CITEDResource in Zotero) will be incorporated at 1pm UTC today (May 27)
2. Glossary will be incorporated near COB today UTC (May 27).
3. 10 UTC on May 28 is the close time for comments on the 5th release.
Please feel free to add comments on the link provided by Anne.
Dawei
Dr. Dawei Lin, Ph.D.
Associate Director for Bioinformatics and Senior Advisor to the Director
Division of Allergy, Immunology, and Transplantation
National Institute of Allergy and Infectious Diseases
5601 Fisher’s Lane 7A70, MSC 9828
Rockville MD, 20852
Work phone: 240-627-3527
Cell Phone: 301-312-3986
From: MartinHITS via RDA-COVID19-Clinical
Reply-To: “***@***.***-its.org
Date: Wednesday, May 27, 2020 at 3:12 AM
To: “***@***.***-tlse3.fr” , “***@***.***-groups.org” , Philippe Després
, “Farahani, Keyvan (NIH/NCI) [E]”
Subject: [rda-covid19-clinical] Re: [rda-covid19-clinical][rdacovid19-coordination] Re: Clinical Sub-Group Meeting 27 May 1.00 pm UTC
Dear Anne,
Dear all,
Unfortunately, I cannot join today as I have a full day virtual conference today of the EU-STANDS4PM network. As I have a longer presentation to give about standardization exactly when we have subgroup meeting here, sneaking out the other meeting is also not possible.
Sorry,
Martin
——————————————
Martin Golebiewski
HITS gGmbH
Schloss-Wolfsbrunnenweg 35
69118 Heidelberg
Germany
phone +49 6221 533 281
fax +49 6221 533 298
email ***@***.***-its.org
http://www.h-its.org
_________________________________________________
Amtsgericht Mannheim / HRB 337446
Managing Director: Dr. Gesa Schönberger
Scientific Director: PD Wolfgang Müller
Von: im Auftrag von cambonthomsen via RDA-COVID19-Clinical
Antworten an: “***@***.***-tlse3.fr
Datum: Mittwoch, 27. Mai 2020 um 00:48
An: “***@***.***-groups.org” , Philippe Després
, “Farahani, Keyvan (NIH/NCI) [E]” , RDA COVID19 Coordination
Betreff: [rda-covid19-clinical][rdacovid19-coordination] Re: Clinical Sub-Group Meeting 27 May 1.00 pm UTC
Dear RDA COVID-19 Clinical Subgroup members,
Thanks to all the members who attended our RDA COVID-19 Clinical Subgroup weekly meeting last week and contributed to improve the document that will be the basis of the next release this Friday. We are grateful for your dedication to the group.
Please join our meeting at 1.00 PM UTC Wednesday 27 May 2020 via this link https://global.gotomeeting.com/join/903049133 ;
This will be dedicated to finalise the content and all elements to refine the content of our part of the final document. Your presence is very important. You’ll find the points for discussion in the rolling agenda at the following link : https://docs.google.com/document/d/1KLL5uBdG8ldNxQDiQ1IiKjXvlz6h9I9gsGd7
Even if you cannot make it for this meeting and have contributed to the work of the group it is absolutely necessary you check that your name and ORCID number are mentioned in the list of contributors, and if not please add it ; the contributor spreadsheet is here
Agenda points pasted in this mail for your convenience : input and discussion needed for each point.
1.
1.
2. Updates on where
3. we stand (document on its way for the
4. 5th release)
5. (Dawei). – Comments from the webinar and Co-Moderators/co-Chairs meeting on 26 May
1.
2.
1.
2. Reminder of
3. Timeline
4. and next
5. steps (Anne)
1.
2.
1.
2. Editorial
3. guidelines
4. for reference
1.
2.
1.
2. Come up a few bullets
3. for the subgroup to highlight the most important rec/guidelines for press
4. release and executive summary input document
1.
2.
1.
2. Ensure we have all
3. contributors;
4. contributors spreadsheet
1.
2.
1.
2. Work with Sergio
3. to get important resources to the “other resource” section of the document (Sergio plus other co-moderators)
1.
2.
1.
2. Check all necessary
3. terms are in glossary
1.
2.
1.
2. Information regarding
3. the navigation tree group (Notes here
4. )
1.
2.
1.
2. Update on input from
3. the Legal-ethical sub-group for our issues
1.
2.
1.
2. AOB
1.
Waiting forward to our meeting,
Sincerely,
Co-Moderators: Sergio Bonini (***@***.***), Andrea Jackson-Dipina (***@***.***), Dawei Lin (***@***.***), Christian Ohmann ( ***@***.***-duesseldorf.de )
Co-Chair Liaison: Anne Cambon-Thomsen (***@***.***-tlse3.fr)
Please join the meeting from your computer, tablet or smartphone.
https://global.gotomeeting.com/join/903049133
You can also dial in using your phone.
United States: +1 (312) 757-3117
Access Code: 903-049-133
More phone numbers
Australia: +61 2 8355 1038
Austria: +43 7 2081 5337
Belgium: +32 28 93 7002
Canada: +1 (647) 497-9373
Denmark: +45 32 72 03 69
Finland: +358 923 17 0556
France: +33 170 950 590
Germany: +49 892 0194 301
Ireland: +353 15 295 146
Italy: +39 0 291 29 46 27
Netherlands: +31 202 251 001
New Zealand: +64 9 913 2226
Norway: +47 21 93 37 37
Spain: +34 932 75 1230
Sweden: +46 853 527 818
Switzerland: +41 225 4599 60
United Kingdom: +44 808 178 0872
New to GoToMeeting? Get the app now and be ready when your first meeting starts:
https://global.gotomeeting.com/install/903049133

Dr Anne Cambon-Thomsen
Directrice de recherche émérite au CNRS
UMR 1027, Inserm, Univ Toulouse III – Paul Sabatier http://www.u1027.inserm.fr
Plateforme sociétale genotoul http://societal.genotoul.fr/
37 allées Jules Guesde F-31000 Toulouse
Tel : +33 (0)5 61 14 59 59 (assistante Nina Segura: 56 19 ou
Mobile: +33 (0)6 79 41 13 48 Fax : +33 (0)5 61 14 56 23 Skype: act_pro
E-mail :